Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence

被引:60
|
作者
Chan, Kun-Ming [1 ]
Tsai, Chun-Yi [1 ]
Yeh, Chun-Nan [1 ]
Yeh, Ta-Sen [1 ]
Lee, Wei-Chen [1 ]
Jan, Yi-Yin [1 ]
Chen, Miin-Fu [1 ]
机构
[1] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Coll Med, Dept Gen Surg, 5 Fu Hsing St, Taoyuan 33305, Taiwan
来源
BMC GASTROENTEROLOGY | 2018年 / 18卷
关键词
Intrahepatic cholangiocarcinoma; Curative resection; Recurrence; Prognostic factors; Outcome; HEPATOCELLULAR-CARCINOMA; CLINICAL-FEATURES; VIRUS-INFECTION; RISK-FACTORS; LONG-TERM; HEPATECTOMY; POPULATION; SURVIVAL;
D O I
10.1186/s12876-018-0912-x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundIntrahepatic cholangiocarcinoma (ICC) is a relatively rare subtype of cholangiocarcinoma. The study herein gathered experience of surgical treatment for ICC, and aimed to analyze the prognosis of patients who had received curative-intent liver resection.MethodsA total of 216 patients who had undergone curative-intent liver resection for ICC between January 1977 and December 2014 was retrospectively reviewed.ResultsOverall, the rates of 5-years recurrence-free survival (RFS) and overall survival (OS) were 26.1 and 33.9% respectively. Based on multivariate analysis, four independent adverse prognostic factors including morphology patterns, maximum tumor size >5cm, pathological lymph node involvement, and vascular invasion were identified as affecting RFS after curative-intent liver resection for ICC. Among patients with cholangiocarcinoma recurrence, only 27 (16.9%) were able to receive surgical resection for recurrent cholangiocarcinoma that had a significantly better outcome than the remaining patients.ConclusionDespite curative resection, the general outcome of patients with ICC is still unsatisfactory because of a high incidence of cholangiocarcinoma recurrence after operation. Tumor factors associated with cholangiocarcinoma remain crucial for the prognosis of patients with ICC after curative liver resection. Moreover, aggressive attitude toward repeat resection for the postoperative recurrent cholangiocarcinoma could provide a favorable outcome for patients.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence
    Kun-Ming Chan
    Chun-Yi Tsai
    Chun-Nan Yeh
    Ta-Sen Yeh
    Wei-Chen Lee
    Yi-Yin Jan
    Miin-Fu Chen
    BMC Gastroenterology, 18
  • [2] Locoregional recurrence in intrahepatic cholangiocarcinoma after curative resection
    Kim, K.
    Song, S.
    Chie, E. K.
    Jang, J. Y.
    Kim, S. W.
    Lee, N. J.
    Suh, K. S.
    Ha, S. W.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S76 - S76
  • [3] Preoperative neutrophil-to-lymphocyte ratio is prognostic for early recurrence after curative intrahepatic cholangiocarcinoma resection
    Choi, Woo Jin
    Perez, Fiorella Murillo
    Gravely, Annabel
    Ivanics, Tommy
    Claasen, Marco P. A. W.
    Abraham, Liza
    Abreu, Phillipe
    Visser, Robin
    Gallinger, Steven
    Hansen, Bettina E.
    Sapisochin, Gonzalo
    ANNALS OF HEPATO-BILIARY-PANCREATIC SURGERY, 2023, 27 (02) : 158 - 165
  • [4] Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent
    Zhang, X-F
    Beal, E. W.
    Bagante, F.
    Chakedis, J.
    Weiss, M.
    Popescu, I.
    Marques, H. P.
    Aldrighetti, L.
    Maithel, S. K.
    Pulitano, C.
    Bauer, T. W.
    Shen, F.
    Poultsides, G. A.
    Soubrane, O.
    Martel, G.
    Koerkamp, B. G.
    Itaru, E.
    Pawlik, T. M.
    BRITISH JOURNAL OF SURGERY, 2018, 105 (07) : 848 - 856
  • [5] Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection
    Li, Tao
    Qin, Lun-Xiu
    Zhou, Jian
    Sun, Hui-Chuan
    Qiu, Shuang-Jian
    Ye, Qing-Hai
    Wang, Lu
    Tang, Zhao-You
    Fan, Jia
    LIVER INTERNATIONAL, 2014, 34 (06) : 953 - 960
  • [6] IS LATERAL RECURRENCE AFTER CURATIVE RESECTION OF RECTAL CANCER A PROGNOSTIC FACTOR FOR POOR OUTCOME?
    Uehara, K.
    Aiba, T.
    Ogura, A.
    Kodera, Y.
    Ebata, T.
    DISEASES OF THE COLON & RECTUM, 2021, 64 (05)
  • [7] Prognostic significance for recurrence of fibroblast growth factor receptor 2 in intrahepatic cholangiocarcinoma patients undergoing curative hepatic resection
    Toshida, Katsuya
    Itoh, Shinji
    Yugawa, Kyohei
    Kosai, Yukiko
    Tomino, Takahiro
    Yoshiya, Shohei
    Nagao, Yoshihiro
    Kayashima, Hiroto
    Harada, Noboru
    Kohashi, Kenichi
    Oda, Yoshinao
    Yoshizumi, Tomoharu
    HEPATOLOGY RESEARCH, 2023, 53 (05) : 432 - 439
  • [8] Isolated anti-HBc is an independent risk factor for tumor recurrence in intrahepatic cholangiocarcinoma after curative resection
    Xiao-Bo Xu
    Chen Hu
    Han-Jin Yang
    Shu-Sen Zheng
    Hepatobiliary&PancreaticDiseasesInternational, 2022, 21 (05) : 472 - 478
  • [9] Isolated anti-HBc is an independent risk factor for tumor recurrence in intrahepatic cholangiocarcinoma after curative resection
    Xu, Xiao-Bo
    Hu, Chen
    Yang, Han-Jin
    Zheng, Shu-Sen
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2022, 21 (05) : 472 - 478
  • [10] Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy
    S. Song
    K. Kim
    E. K. Chie
    S. Kim
    H. J. Park
    N. J. Yi
    K.-S. Suh
    S. W. Ha
    Clinical and Translational Oncology, 2015, 17 : 825 - 829